0001209191-21-010231.txt : 20210212 0001209191-21-010231.hdr.sgml : 20210212 20210212171353 ACCESSION NUMBER: 0001209191-21-010231 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201231 FILED AS OF DATE: 20210212 DATE AS OF CHANGE: 20210212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Laskow-Pooley David CENTRAL INDEX KEY: 0001638533 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37939 FILM NUMBER: 21629583 MAIL ADDRESS: STREET 1: C/O TAPIMMUNE INC. STREET 2: 1551 EASTLAKE AVE. CITY: SEATTLE STATE: WA ZIP: 98102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Marker Therapeutics, Inc. CENTRAL INDEX KEY: 0001094038 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 880277072 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3200 SOUTHWEST FREEWAY STREET 2: SUITE 2500 CITY: HOUSTON STATE: TX ZIP: 77027 BUSINESS PHONE: (713) 400-6400 MAIL ADDRESS: STREET 1: 3200 SOUTHWEST FREEWAY STREET 2: SUITE 2500 CITY: HOUSTON STATE: TX ZIP: 77027 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC. DATE OF NAME CHANGE: 20170629 FORMER COMPANY: FORMER CONFORMED NAME: TAPIMMUNE INC DATE OF NAME CHANGE: 20070628 FORMER COMPANY: FORMER CONFORMED NAME: GENEMAX CORP DATE OF NAME CHANGE: 20020718 5 1 doc5.xml FORM 5 SUBMISSION X0306 5 2020-12-31 0 0 1 0001094038 Marker Therapeutics, Inc. MRKR 0001638533 Laskow-Pooley David 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 1 0 0 0 Common Stock 2020-05-19 4 A 0 L 17022 0.00 A 42565 D Represents the portion of the annual board retainer for each non-employee director payable in immediately vested common stock under the Company's 2014 Omnibus Stock Ownership Plan, as amended and based on the closing price of $2.35 per share, on the day immediately preceding the date of the Company's 2019 annual meeting. /s/ Michael Loiacono, Attorney-in-Fact 2021-02-12